ライフサイエンスコーパス: stress disorder

1 sorders such as addiction and post-traumatic stress disorder.

2 drug class as a treatment for posttraumatic stress disorder.

3 ch as depression, anxiety, and posttraumatic stress disorder.

4 ypertension to 0.6 per 100 for posttraumatic stress disorder.

5 he clinic for the treatment of posttraumatic stress disorder.

6 g-term psychologic symptoms of posttraumatic stress disorder.

7 l behavior in a mouse model of posttraumatic stress disorder.

8 neralized anxiety disorder and posttraumatic stress disorder.

9 ck women's heightened risk for posttraumatic stress disorder.

10 tral sensory hyperactivity in post-traumatic stress disorder.

11 al aetiological mechanism for post-traumatic stress disorder.

12 is an effective treatment for posttraumatic stress disorder.

13 sorders, including anxiety and posttraumatic stress disorder.

14 , such as chronic anxiety and post-traumatic stress disorder.

15 essive-compulsive disorder, or posttraumatic stress disorder.

16 ns, with a particular focus on posttraumatic stress disorder.

17 including major depression and posttraumatic stress disorder.

18 ry prevention and treatment of posttraumatic stress disorder.

19 as autism, schizophrenia, and posttraumatic stress disorder.

20 ession, bipolar disorder, and post-traumatic stress disorder.

21 muli in models of anxiety and post-traumatic stress disorder.

22 at captures features of human post-traumatic stress disorder.

23 or use in pharmacotherapy for post-traumatic stress disorder.

24 ated with reduced symptoms of post-traumatic stress disorder.

25 ory-related disorders such as post-traumatic stress disorder.

26 sychiatric illnesses, such as post-traumatic stress disorder.

27 d treatment of disorders like post-traumatic stress disorder.

28 ted memory disorders, such as post-traumatic stress disorder.

29 sychiatric disorders, such as post-traumatic stress disorder.

30 treatment for depression and post-traumatic stress disorder.

31 context of the development of post-traumatic stress disorder.

32 eriences that contributes to the symptoms of stress disorders.

33 tcomes such as substance abuse and traumatic stress disorders.

34 strated to be useful to treat post-traumatic stress disorders.

35 s of depression, anxiety, and post-traumatic stress disorder 1 year after flooding.

36 ety 1.66 (1.12-2.46), and for post-traumatic stress disorder 1.70 (1.17-2.48) than people who were no

37 d showed reduced prevalence of posttraumatic stress disorder (45% vs 69%; p = 0.01), anxiety (45% vs

38 for memory disorders such as post-traumatic stress disorder(5).

39 ay even increase prevalence of posttraumatic stress disorder (52.4% vs 37.1%; p = 0.03).

40 mpact of Event Scale-Revised (post-traumatic stress disorder); 6-minute walk; and/or the EuroQol-5D-5

41 (PTSD) was measured with the Post-traumatic Stress Disorder 8 items (PTSD-8) and severe mental illne

42 st expansion of research into post-traumatic stress disorder accompanied revisions to the classificat

43 hiatric disorders (depression, posttraumatic stress disorder, addiction, social anxiety disorder, bip

44 ignificant after adjusting for posttraumatic stress disorder (adjusted RR = 1.34, 95% confidence inte

45 that might offset the risk of post-traumatic stress disorder after cardiovascular disease events.

46 f the exposed parent, parental posttraumatic stress disorder, age at Holocaust exposure) and offsprin

47 Interestingly, patients with post-traumatic stress disorder also showed heightened frontal processin

48 lated quality of life, but not posttraumatic stress disorder among ICU survivors and may result in le

49 rvivors and may result in less posttraumatic stress disorder among relatives of ICU patients.

50 Posttraumatic stress disorder, an area of large unmet medical needs, i

51 s of depression, anxiety, and post-traumatic stress disorder and 4.0% (95% UI 2.9-5.5) for moderate f

52 Post-traumatic stress disorder and anxiety are more prevalent in the ve

53 New possibilities for treating posttraumatic stress disorder and anxiety disorders involving abnormal

54 nt overlap of symptoms between posttraumatic stress disorder and anxiety disorders, the latter has re

55 review of sleep disturbance in posttraumatic stress disorder and anxiety-related disorders.

56 chanisms for the link between post-traumatic stress disorder and cardiovascular disease, and several

57 Post-traumatic stress disorder and cocaine use disorder are highly co-m

58 may enhance susceptibility to posttraumatic stress disorder and comorbid conditions such as major de

59 ia), mental health status (eg, posttraumatic stress disorder and depression), nonocular pain, and med

60 s also observed on measures of posttraumatic stress disorder and depression.

61 eurosteroidogenesis, including posttraumatic stress disorder and major depressive disorder.

62 vity in patients with comorbid posttraumatic stress disorder and MDD.

63 ility, a phenotype related to post-traumatic stress disorder and propose that this phenotype is media

64 for two psychiatric outcomes (post-traumatic stress disorder and schizophrenia) and one psychosocial

65 ly two psychiatric disorders (post-traumatic stress disorder and schizophrenia) and one psychosocial

66 regression to estimate associations between stress disorders and dementia.

67 isorders, as well as the interaction between stress disorders and sex in predicting dementia, in Denm

68 f stress responses, and interactions between stress disorders and sex.

69 er, major depressive disorder, posttraumatic stress disorder, and addiction.

70 atment of depression, anxiety, posttraumatic stress disorder, and also against age-related cognitive

71 the apolipoprotein E4 allele, post-traumatic stress disorder, and genetic risk for schizophrenia and

72 ed schizophrenia, depression, post-traumatic stress disorder, and obsessive-compulsive disorder, and

73 -related cognitive impairment, posttraumatic stress disorder, and traumatic brain injury.

74 levels of anxiety, depression, posttraumatic stress disorders, and/or complicated grief.

75 outcomes included history of post-traumatic-stress-disorder, anesthesia type, first or second eye, p

76 chiatric conditions, including posttraumatic stress disorder, anxiety disorders, obsessive-compulsive

77 disorders (any disorder, mood, posttraumatic stress disorder, anxiety, alcohol use disorders, drug us

78 orted a greater prevalence of post-traumatic stress disorder, anxiety, or depression than did control

79 erapeutic effects for treating posttraumatic stress disorder are related to altering emotional memory

80 persons with a range of clinician-diagnosed stress disorders, as well as the interaction between str

81 ypes of firearms on readmission due to acute stress disorder (ASD) and/or post-traumatic stress disor

82 d by peritraumatic symptoms and 2-week acute stress disorder (ASD).

83 ep quality, somatic symptoms, post-traumatic stress disorder, being overweight and negatively loaded

84 s of depression, anxiety, and post-traumatic stress disorder between participants displaced by floodi

85 sorders (depression, anxiety, post-traumatic stress disorder, bipolar disorder, and schizophrenia) wa

86 depression, anxiety disorder, post-traumatic stress disorder, bipolar disorder, and schizophrenia.

87 (mean scores >35), followed by posttraumatic stress disorder, borderline personality disorder, and co

88 ies are prominent features of post-traumatic stress disorder, but the mechanisms supporting their dev

89 disorders, mood disorders, and posttraumatic stress disorder by sexual identity (heterosexual, bisexu

90 salient stressor, such as in post-traumatic stress disorder, can have lasting impacts upon an indivi

91 psychologic diagnoses such as post-traumatic stress disorder, cardiovascular disease, and dementia ha

92 vents is a hallmark symptom of posttraumatic stress disorder, characterized by rich and vivid sensory

93 umatic stress (measured by the Posttraumatic Stress Disorder Checklist [PCL]), personally identified

94 ess disorder (measured by the Post-Traumatic Stress Disorder Checklist [PCL]-6 scale).

95 er patient discharge using the Posttraumatic Stress Disorder Checklist-Civilian Version, the Patient

96 at hospital discharge via the Posttraumatic Stress Disorder Checklist-Specific scale; a suggested di

97 ienced higher risk of lifetime posttraumatic stress disorder compared with white women.

98 ms of anxiety, depression, or post-traumatic stress disorder) critical illness that can be used to id

99 act of psychiatric conditions (posttraumatic stress disorder, depression, anxiety, and substance abus

100 included Danes aged 40 years or older with a stress disorder diagnosis (n = 47,047) and a matched com

101 ed comparison cohort (n = 232,141) without a stress disorder diagnosis with data from 1995 through 20

102 pears that the development of post-traumatic stress disorder drives cocaine use vulnerability.

103 igence was not associated with posttraumatic stress disorder, eating disorders, and anxiety disorders

104 major depressive disorder and posttraumatic stress disorder, exact enormous socioeconomic and indivi

105 ith a higher rate of dementia among men with stress disorders except posttraumatic stress disorder, f

106 o the potential development of posttraumatic stress disorder following trauma.

107 n with stress disorders except posttraumatic stress disorder, for which women had a higher rate.

108 The onset of post-traumatic stress disorder generally occurs prior to the developmen

109 Ultrasound propagation through externally stressed, disordered granular materials was experimental

110 sychiatric conditions and with posttraumatic stress disorder having the largest impact.

111 system has been implicated in posttraumatic stress disorder; however, the mechanisms responsible for

112 tial therapeutic utility in the treatment of stress disorders; however, additional preclinical charac

113 .23, p < 0.001), particularly post-traumatic stress disorder (HR 9.33, 95% CI 7.96-10.94, p < 0.001),

114 imary outcome was symptoms of post-traumatic stress disorder in family members 90 days after patient

115 rs4523957, is associated with posttraumatic stress disorder in humans, consistent with the facilitat

116 ies that underlie anxiety and post-traumatic stress disorders in humans.

117 s evidence of an interaction between sex and stress disorders in predicting dementia, with a higher r

118 nding of the molecular mechanisms underlying stress disorders in which excessive avoidance results in

119 alence of major depressive and posttraumatic stress disorders in women compared with men, most clinic

120 , a validated rodent model of post-traumatic stress disorder, in combination with optogenetic activat

121 sychiatric conditions such as post-traumatic stress disorder, in which aversive experiences are often

122 We conclude that post-traumatic stress disorder is a risk factor for incident cardiovasc

123 Posttraumatic stress disorder is often comorbid with MDD, and symptoms

124 ety, obsessive-compulsive, and posttraumatic stress disorders is unclear.

125 ing mental disorders, such as post-traumatic stress disorder, little is known about the source of ind

126 r [GAD]-2 anxiety scale), and post-traumatic stress disorder (measured by the Post-Traumatic Stress D

127 stem, a known risk factor for post-traumatic stress disorder, modulates the stress-induced shift from

128 ptoms linked to deployment are posttraumatic stress disorder, mood disorders, GI problems and chronic

129 jects (n = 20), patients with post-traumatic stress disorder (n = 25) demonstrated intrinsic sensory

130 unipolar depression, n = 92; post-traumatic stress disorder, n = 91; obsessive-compulsive disorder,

131 e formation and persistence of posttraumatic stress disorder, of which sleep impairments are a core f

132 ntrolled trial; n=30), 12 for post-traumatic stress disorder (one randomised controlled trial; n=10),

133 ated with pathologies such as post-traumatic stress disorder or autism; however, the underlying mecha

134 een relatively little study of posttraumatic stress disorder or obsessive-compulsive disorder to date

135 priori seeds relevant to TMS, posttraumatic stress disorder, or MDD (subgenual anterior cingulate co

136 er (ADHD), Tourette syndrome, post-traumatic stress disorder, or psychosis, either as the primary con

137 disorder, Tourette syndrome, post-traumatic stress disorder, or psychosis.

138 Here, we describe mGluR5 findings in stress disorders, particularly major depressive disorder

139 IFICANCE STATEMENT Anxiety and posttraumatic stress disorder patients generalize fear to nonfearful f

140 psychiatric disorders such as posttraumatic stress disorder, PFC hyperactivity is associated with in

141 VC characteristics with 8-week posttraumatic stress disorder (PTSD) adjusting for pre-MVC PTSD and me

142 ce of anxiety, depression, and posttraumatic stress disorder (PTSD) after injury and their associatio

143 urce loss is a core driver of post-traumatic stress disorder (PTSD) after large-scale traumatic event

144 a exposure is known to predict posttraumatic stress disorder (PTSD) after subsequent traumas, it is u

145 stressful experiences, such as posttraumatic stress disorder (PTSD) and depression, are not well unde

146 tionately have higher rates of posttraumatic stress disorder (PTSD) and experience greater symptom se

147 nce-based "2-hit" rat model of posttraumatic stress disorder (PTSD) and identified predictors and bio

148 perarousal symptoms, including posttraumatic stress disorder (PTSD) and major depression.

149 inically relevant subtypes of post-traumatic stress disorder (PTSD) and major depressive disorder (MD

150 58) were assessed for probable posttraumatic stress disorder (PTSD) and probable depression.

151 chiatric disorders, including post-traumatic stress disorder (PTSD) and psychosis, compared with othe

152 ories is relevant for treating posttraumatic stress disorder (PTSD) and related syndromes, which deve

153 re altered in association with posttraumatic stress disorder (PTSD) and resilience.

154 tes to the pathophysiology of post-traumatic stress disorder (PTSD) and that anti-inflammatory drugs

155 RP) have been associated with post-traumatic stress disorder (PTSD) and traumatic experiences, but th

156 s "breakthrough therapies" for posttraumatic stress disorder (PTSD) and treatment-resistant depressio

157 has enhanced extinction in a post-traumatic stress disorder (PTSD) animal model and was related to r

158 Part of the symptomatology of post-traumatic stress disorder (PTSD) are alterations in arousal and re

159 KEY POINTS: Patients with post-traumatic stress disorder (PTSD) are at a significantly higher ris

160 f the presence and severity of posttraumatic stress disorder (PTSD) are elusive, yet badly needed.

161 umatic brain injury (TBI) and post-traumatic stress disorder (PTSD) are risk factors for Parkinson's

162 idate the mechanisms by which post-traumatic stress disorder (PTSD) at a young age contributes to an

163 life trauma (ELT) exposure and posttraumatic stress disorder (PTSD) both affect neural structure, whi

164 events are at risk of not only posttraumatic stress disorder (PTSD) but also other mental health como

165 r TBI might contribute to TBI-post traumatic stress disorder (PTSD) comorbidity.

166 increased risk for developing post-traumatic stress disorder (PTSD) compared with the general populat

167 The risk of posttraumatic stress disorder (PTSD) following trauma is heritable, bu

168 urobiological understanding of posttraumatic stress disorder (PTSD) has been partially attributed to

169 Posttraumatic stress disorder (PTSD) has increasingly been linked to h

170 Post-traumatic stress disorder (PTSD) impacts many veterans and active

171 Posttraumatic stress disorder (PTSD) in adolescents is common and debi

172 stress disorder (ASD) and/or post-traumatic stress disorder (PTSD) in firearm-injury victims.

173 biases in disorders including post-traumatic stress disorder (PTSD) in humans.

174 ical dispensaries for treating posttraumatic stress disorder (PTSD) in many states of the union, yet

175 ogical mechanisms that predict posttraumatic stress disorder (PTSD) in recent trauma survivors is imp

176 ated with trauma exposure and post-traumatic stress disorder (PTSD) in young people.

177 Post-traumatic stress disorder (PTSD) is a common, debilitating conditi

178 Post-traumatic stress disorder (PTSD) is a debilitating disorder that d

179 Posttraumatic stress disorder (PTSD) is a debilitating psychiatric dis

180 Post-traumatic stress disorder (PTSD) is a heterogeneous condition evid

181 Posttraumatic stress disorder (PTSD) is a highly prevalent psychiatric

182 Post-traumatic stress disorder (PTSD) is a major problem among military

183 Posttraumatic stress disorder (PTSD) is a prevalent and highly disabli

184 Posttraumatic stress disorder (PTSD) is a stress disorder that develop

185 ABSTRACT: Post-traumatic stress disorder (PTSD) is associated with increased card

186 Post-traumatic stress disorder (PTSD) is characterized by emotional hyp

187 Post-traumatic stress disorder (PTSD) is characterized by exaggerated f

188 Post-traumatic stress disorder (PTSD) is characterized by persistent fe

189 We therefore postulated that posttraumatic stress disorder (PTSD) may be associated with increased

190 Posttraumatic stress disorder (PTSD) may contribute to heightened card

191 Posttraumatic stress disorder (PTSD) may develop when mechanisms for m

192 me-wide association studies of posttraumatic stress disorder (PTSD) may inform risk for this disorder

193 d psychotherapy treatments for posttraumatic stress disorder (PTSD) provide insufficient benefit for

194 Studies of posttraumatic stress disorder (PTSD) report volume abnormalities in mu

195 CANCE STATEMENT Patients with post-traumatic stress disorder (PTSD) show heightened amygdala activity

196 remature birth can present as post-traumatic stress disorder (PTSD) symptoms and can in turn reinforc

197 correlates of cancer-related post-traumatic stress disorder (PTSD) symptoms and diagnoses.

198 tive threat learning to overt post-traumatic stress disorder (PTSD) symptoms in combat veterans.

199 lence for clinically important posttraumatic stress disorder (PTSD) symptoms of 25%.

200 Primary outcome was post-traumatic stress disorder (PTSD) symptoms or caseness, and seconda

201 We assessed patients' mood, post-traumatic stress disorder (PTSD) symptoms, and QOL 6 months post-t

202 unit (ICU) might reduce their posttraumatic stress disorder (PTSD) symptoms.

203 The increased prevalence of post-traumatic stress disorder (PTSD) that is observed in women may inv

204 er organization in people with posttraumatic stress disorder (PTSD) using diffusion MRI (dMRI), but t

205 The prevalence of posttraumatic stress disorder (PTSD) was 31.46% (95% CI 24.43-38.5), t

206 Post-traumatic stress disorder (PTSD) was measured with the Post-trauma

207 luding anxiety, depression or post-traumatic stress disorder (PTSD)(2-4).

208 tential therapeutic target for posttraumatic stress disorder (PTSD), a mental illness characterized b

209 ing, 20% screened positive for posttraumatic stress disorder (PTSD), all SF-12 physical health subdom

210 order (MDD), 50 patients with post-traumatic stress disorder (PTSD), and 122 healthy controls (HCs).

211 ampus atrophy is implicated in posttraumatic stress disorder (PTSD), and may partly reflect stress-in

212 ated for depression, anxiety, post-traumatic stress disorder (PTSD), and suicidal behaviour.

213 campal and amygdala volumes in posttraumatic stress disorder (PTSD), but findings have not always bee

214 is a first-line treatment for posttraumatic stress disorder (PTSD), but its mechanisms are poorly un

215 is an effective treatment for posttraumatic stress disorder (PTSD), but many patients do not respond

216 lume is frequently observed in posttraumatic stress disorder (PTSD), but the psychological processes

217 and psychopathology, including posttraumatic stress disorder (PTSD), depression, and alcohol-use diso

218 post-deployment screening for post-traumatic stress disorder (PTSD), depression, anxiety, or alcohol

219 tened systemic inflammation in posttraumatic stress disorder (PTSD), few studies have assessed whethe

220 rotein, have been described in posttraumatic stress disorder (PTSD), generalized anxiety disorder (GA

221 ess-related disorders, such as posttraumatic stress disorder (PTSD), is a prominent example where inc

222 neurobiological correlates of post-traumatic stress disorder (PTSD), little is known about its molecu

223 ted psychopathologies, such as posttraumatic stress disorder (PTSD), that are characterized by unwant

224 eripheral immune activation in posttraumatic stress disorder (PTSD), there are no studies of brain im

225 ct of traumatic experience on post-traumatic stress disorder (PTSD), this study aims to explore the a

226 sponse to traumatic stress on post-traumatic stress disorder (PTSD), this study examined longitudinal

227 (CRFR2) to be associated with post-traumatic stress disorder (PTSD)-like symptoms.

228 disorders such as phobias and post-traumatic stress disorder (PTSD).

229 mptoms, prior head injury, and posttraumatic stress disorder (PTSD).

230 her resilient or vulnerable to posttraumatic stress disorder (PTSD).

231 ertraline for the treatment of posttraumatic stress disorder (PTSD).

232 rospective risk for developing posttraumatic stress disorder (PTSD).

233 depressive disorder (MDD) and post-traumatic stress disorder (PTSD).

234 , Schizophrenia, anxiety, and Post Traumatic Stress Disorder (PTSD).

235 stress and the development of post-traumatic stress disorder (PTSD).

236 auma-related disorders such as posttraumatic stress disorder (PTSD).

237 g trauma subsequently develop post-traumatic stress disorder (PTSD).

238 of mental disorders, including posttraumatic stress disorder (PTSD).

239 m spectrum disorder (ASD) and post-traumatic stress disorder (PTSD).

240 psychopathologies, including post-traumatic stress disorder (PTSD).

241 e of the defining features of post-traumatic stress disorder (PTSD).

242 over time into the syndrome of posttraumatic stress disorder (PTSD).

243 ve interventions available for posttraumatic stress disorder (PTSD).

244 k of emotional disorders like post-traumatic stress disorder (PTSD).

245 nsistent with some aspects of post-traumatic stress disorder (PTSD).

246 o reduce the burden of chronic posttraumatic stress disorder (PTSD).

247 ng their propensity to develop posttraumatic stress disorder (PTSD).

248 urological disorder (FND) and post-traumatic stress disorder (PTSD).

249 pted as a pathogenic marker of posttraumatic stress disorder (PTSD).

250 a potential new treatment for post-traumatic stress disorder (PTSD).

251 s, and to risk and symptoms of posttraumatic stress disorder (PTSD).

252 ress-related disorders such as posttraumatic stress disorder (PTSD).

253 commonly reported symptoms in post-traumatic stress disorder (PTSD).

254 d may be at increased risk for posttraumatic stress disorder (PTSD).

255 re of panic disorder (PD) and post-traumatic stress disorder (PTSD).

256 ychiatric disorders, including posttraumatic stress disorder (PTSD).

257 of childhood abuse and current posttraumatic stress disorder (PTSD).

258 is a vulnerability factor for posttraumatic stress disorder (PTSD); however, our understanding is li

259 of daily pain; screening for post-traumatic stress disorder (PTSD); new functional limitations; retu

260 ration (VA) have a history of post-traumatic-stress-disorder (PTSD), and there exists a higher rate o

261 he renin-angiotensin system in posttraumatic stress disorder remain unknown.

262 Patients with post-traumatic-stress-disorder reported higher pain scores, had longer

263 a unique sensory pathology of post-traumatic stress disorder (ruling out effects merely reflecting an

264 y, substance use, personality, posttraumatic stress disorder, schizophrenia, and psychotic disorders)

265 % CI, 1.02-1.30; P = .02), and posttraumatic stress disorder score (OR, 1.04; 95% CI, 1.01-1.08; P =

266 xiety disorders were included: posttraumatic stress disorder, social anxiety disorder, generalized an

267 m datasets from depression and posttraumatic stress disorder studies have identified major gene expre

268 lead to improved diagnosis and treatment for stress disorders such as PTSD, that result in decreased

269 ife events, and depressive and posttraumatic-stress-disorder symptom scores with placental mtDNAcn in

270 Posttraumatic stress disorder symptomatology is common after cardiac a

271 An in-person posttraumatic stress disorder symptomatology was assessed at hospital

272 zero) had higher frequency of posttraumatic stress disorder symptoms (adjusted odds ratio, 2.25; 95%

273 equent hospitalization-induced posttraumatic stress disorder symptoms (cardiac arrest-induced posttra

274 The prevalence of long-term posttraumatic stress disorder symptoms among family members of acute r

275 family-member risk factors for posttraumatic stress disorder symptoms among family members of survivo

276 the ICU discharge to predict post-traumatic stress disorder symptoms at 3 months, the area under the

277 increased lifetime stress and posttraumatic stress disorder symptoms explained the majority of the e

278 Family member risk factors for posttraumatic stress disorder symptoms included preexisting mental hea

279 ted significant improvement in posttraumatic stress disorder symptoms of relatives of ICU survivors;

280 Posttraumatic stress disorder symptoms were present in 31% (95% CI, 24

281 ificant reduction in patients' posttraumatic stress disorder symptoms with ICU diaries (risk ratio, 0

282 The primary outcome was posttraumatic stress disorder symptoms, and secondary outcomes were sy

283 e are more at risk to develop post-traumatic stress disorder symptoms.

284 ere not associated with family posttraumatic stress disorder symptoms.

285 ents are at increased risk for posttraumatic stress disorder symptoms.

286 ol, fuelling and perpetuating post-traumatic stress disorder symptoms.

287 ths were considered as having post-traumatic stress disorder symptoms.

288 atients at risk of developing post-traumatic stress disorder symptoms.

289 dentified as risk factors for post-traumatic stress disorder symptoms.

290 es, more women presented with post-traumatic stress disorder than did men in two studies, and landmin

291 er than expected frequency of post-traumatic stress disorder than other traumatic events.

292 Risk of dementia was higher for persons with stress disorders than for persons without such diagnosis

293 Posttraumatic stress disorder (PTSD) is a stress disorder that develops in only some individuals f

294 construct a vicious cycle in post-traumatic stress disorder that is in action even at rest, implicat

295 ta suggests that a history of post-traumatic-stress-disorder was correlated with higher pain scores,

296 n, severe anxiety, and severe post-traumatic stress disorder) was 5.1% (95% UI 4.0-6.5).

297 Symptoms of post-traumatic stress disorder were significantly higher preinterventio

298 s of depression, anxiety, and post-traumatic stress disorder were similar to other critically ill pop

299 characterized a rat model of post-traumatic stress disorder with segregation of rats as susceptible

300 rder, depression, anxiety, and posttraumatic stress disorder) with major CVD outcomes (CVD events and